Cargando…
Acquired Coagulopathy and Hemorrhage Secondary to Subcutaneous Heparin Prophylaxis
Unfractionated heparin and low-molecular-weight heparins are commonly used as thromboprophylaxis for hospitalized patients. Though generally considered safe at prophylactic doses, cases of catastrophic hemorrhage have been reported. The proposed mechanism involves bioaccumulation of heparin through...
Autores principales: | Sunseri, Maria, Ahuja, Tania, Wilcox, Tanya, Green, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818886/ https://www.ncbi.nlm.nih.gov/pubmed/29545958 http://dx.doi.org/10.1155/2018/9501863 |
Ejemplares similares
-
Life-threatening hemorrhage following subcutaneous heparin therapy
por: Hudcova, Jana, et al.
Publicado: (2009) -
A case of urgent colonoscopic hemostasis of a cecal hemorrhagic ulceration in a patient receiving heparin for COVID‐19 coagulopathy
por: Yoshida, Naohisa, et al.
Publicado: (2020) -
Common pathway coagulopathy and hemorrhagic edema of infancy
por: Gard, Jye, et al.
Publicado: (2023) -
Allergic anaphylaxis due to subcutaneously injected heparin
por: Anders, Diana, et al.
Publicado: (2013) -
Recurrent secondary postpartum hemorrhages due to placental site vessel subinvolution and local uterine tissue coagulopathy
por: Zubor, Pavol, et al.
Publicado: (2014)